The QualityStocks Daily Tuesday, June 26th, 2018

Today's Top 3 Investment Newsletters

MarketClub Analysis (CLDC) +145.55%

MarketBeat (BSRC) +36.32%

BUYINS.NET (SPHS) +34.82%

The QualityStocks Daily Stock List

Probe Metals, Inc. (PROBF)

OTC Markets, Stockhouse, MarketWatch, InvestorsHub, Morningstar, Barron’s, The Street, Northern Miner, PennyStockHub, Junior Mining Network, Agoracom, 4-Traders, Investopedia, Investing.com, Macroaxis, Marketwired, and Barchart reported on Probe Metals, Inc. (PROBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 2015, Probe Metals, Inc. engages in the acquisition, exploration, and development of gold properties. The Company controls a strategic land package of greater than 1,000-square-kilometers of exploration ground within some of the most prolific gold belts in Quebec - Val d’Or, est Timmins, Casa-Berardi, and Detour Quebec.

Listed on the OTC Markets Group’s OTCQB, Probe Metals has its head office in Toronto, Ontario. The Company was established due to the sale of Probe Mines Limited to Goldcorp in March of 2015. Goldcorp presently owns an approximately 13.7 percent stake in Probe Metals.

The Company’s key asset is the Val-d’Or East Gold Project in Quebec. The Val-d'Or East Project consists of the Pascalis, Lapaska, and Megiscane-Tavernier Properties. The Val d'Or East Project consists of 293 claims totaling 11,904 hectares of land, controlled by Probe Metals, positioned roughly 25 kilometers east of the city of Val-d'Or in Quebec.

The Company also has its Detour Quebec Project. This project includes 100 percent owned properties and the 75 percent Probe-SOQUEM JV (Joint Venture) properties.

Probe Metals other Projects include the Dubuisson property in Dubuisson Township, Quebec; and the Timmins West in Ontario (the Meunier-144 JV property is in the western part of the prolific Timmins gold camp).

Other Projects also include the Casa Cameron Project in Quebec. This Project includes properties situated north of La Sarre, Amos and Lebel-sur-Quevillon, in the northwest region of Quebec.

Probe Metals also has its Black Creek Chromite Project in Ontario. The Black Creek Chromite deposit is in the James Bay Lowlands in a region known as "The Ring of Fire".

In July 2017, Probe Metals announced it completed the earlier disclosed asset purchase of the Aurbel East property from QMX Gold Corporation. This Property is located immediately adjacent to Probe’s Val-d'Or East Project near Val-d'Or, Quebec.

This past October, Probe Metals announced the completion of the earlier announced acquisition of the Courvan property from Monarques Gold Corporation. Probe’s landholdings in Val-d’Or are now 327 square kilometers. This makes it one of the largest consolidated land packages in the Val-d'Or Mining Camp.

Last month, Probe Metals announced the completion of the sale of the West Porcupine property to GFG Resources, Inc.  Probe sold a 100 percent interest in the property to GFG in exchange for the issuance of 6,477,883 common shares of GFG. This represents a value of $3.5 million based on GFG Resources’ 20-day volume weighted average share price (VWAP) ending December 7, 2017.

Yesterday, Probe Metals provided new results from the 2017 drill program at its 100 percent owned Val-d’Or East project. Last year, Probe drilled 83,076 meters in 194 holes at Val-d’Or East. This drill program concentrated on expansion and exploration drilling in and around the New Beliveau gold deposit and also on other gold zones along a 2.5 kilometer strike length within the Pascalis Gold Trend.

Results from 38 holes (PC-17-198 to PC-17-235) totaling 16,104 meters drilled along the Pascalis Gold Trend continue to demonstrate strong potential for expansion and new discoveries surrounding the former Beliveau mine.

Expansion drilling in the Main dyke 300 meters to the south returned major results with intercepts grading 3 g/t Au over 83.1 meters starting at 7 meters depth. This includes 5.3 g/t Au over 13.6 meters, 5.9 g/t Au over 5.5 meters and 10.8 g/t Au over 11.4 meters in Hole PC-17-207.

Mr. David Palmer, Probe Metals’ President and Chief Executive Officer, stated, “It is encouraging to see such strong drilling results from New Beliveau as we finish 2017 and start the 2018 drill program. The success of the drilling at New Beliveau to-date bodes well for continued expansion in the drilling ahead.  In addition to the achievements at New Beliveau, 2017 also saw an expansive regional exploration program that has generated a significant number of priority drill targets, all in areas that have seen very little historic exploration.”

Probe Metals, Inc. (PROBF), closed Tuesday's trading session at $0.98, up 5.38%, on 290,550 volume with 170 trades. The average volume for the last 60 days is 40,620 and the stock's 52-week low/high is $0.7749/$1.4233.

chart

The American Energy Group, Ltd. (AEGG)

Zacks, Stockhouse, GuruFocus, MarketWatch and InvestorsHub reported on The American Energy Group, Ltd. (AEGG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The American Energy Group, Ltd. (AEGG) is an energy resource royalty company. It is a non-operating oil and gas organization. AEGG has an 18 percent gross overriding royalty interest on the producing Yasin Block 2468-7 in South-Central Pakistan, which consists of 539,172 acres. Incorporated in 1987, AEGG is based in Westport, Connecticut. The Company lists on the OTC Markets’ OTCQB.

The original oil producing well in Pakistan dates back to 1887. Nonetheless, major gas reserves were not discovered in the nation until 1952. Regarding Pakistan in-country opportunities, experts view Pakistan as a nation with realistic potential for the discovery of large oil and gas reserves.

AEGG’s other core assets consist of royalties and convertible carried working interests (WI’s) in oil and gas leases. These include a 2.5 percent carried working interest (WI) in Zamzama North Block No. 2667-8 under exploration in South-Central, Sindh Province, Pakistan. Heritage Oil and Gas is the operator. This property consists of 557,951 square acres.

Furthermore, in the Zamzama North and Sanjawi Blocks, AEGG has the option to convert its 2.5 percent carried WI’s at any time, on a well by well basis to a 1.5 percent royalty, free of the costs of exploration and development of the leases. The convertible carried WI is "carried", which means free of exploration and development costs, as to the first three wells for Zamzama North, and the first two wells for Sanjawi.

The Company also has a 2.5 percent carried WI in Sanjawi Block No. 3068-2 under exploration in North-Central, Baluchistan Province, Pakistan. Heritage Oil and Gas is the operator. This property is 302,895 square acres. The other joint venture (JV) partners are Hycarbex-American Energy, Inc, Sprint Energy, and Trakker Energy.

AEGG exposes investors to the considerable upside of drilling activities in Pakistan. This is without the downside risk of exploration and production costs.

AEGG’s strategy is to expand its portfolio of royalty and convertible WI’s in long-term petroleum leases. In addition, the Company’s strategy is to create shareholder value through investing in exploration and early development projects with high cash-flow potential.

AEGG’s emphasis will be high-impact, South Asia energy development opportunities, which are characterized by numerous target structures and locations with a potential for substantial hydrocarbon reserves.

At the end of May, The American Energy Group announced that the Government of Pakistan granted to the Company's wholly owned subsidiary, Hycarbex-American Energy, Inc. an extension to the Yasin Exploration License relating back to the date of the request for extension in March 2013.

Management quickly initiated its plans for exploration and development activities on the Yasin Exploration License based on this extension.  The extension is subject to additional performance requirements regarding seismic, rework of the Haseeb #1 Well and the work program financial obligations that are undergoing review by Management and that will continue to be discussed with the Government of Pakistan as the work at the site moves ahead.

The American Energy Group, Ltd. (AEGG), closed Tuesday's trading session at $0.074, even for the day, on 2,000 volume with 1 trade. The average volume for the last 60 days is 12,228 and the stock's 52-week low/high is $0.0201/$0.0746.

chart

Diego Pellicer Worldwide, Inc. (DPWW)

4-Traders, Stockhouse, Business Insider, StockInvest, Daily Marijuana Observer, MarketWatch, InvestorsHub, Insider Financial, StockAnalyst24, Penny Stock Tweets, and Barchart reported on Diego Pellicer Worldwide, Inc. (DPWW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Diego Pellicer Worldwide, Inc. is a real estate and consumer retail development company. It concentrates on developing the Company as the globe’s first "premium" marijuana brand. Its tenants are stand-alone, independent businesses and Diego Pellicer Worldwide has no ownership in them. Diego Pellicer Worldwide has its corporate office in Seattle, Washington.

Essentially, Diego Pellicer is where responsible marijuana connoisseurs and sommeliers convene to explore the world of premium marijuana. The Company is the worldwide leader in property acquisitions and leasing in the developing cannabis arena.

Diego Pellicer’s initial focus is to acquire and develop legally compliant real estate locations for the purposes of leasing them to State licensed companies in the cannabis industry. The Company’s initial revenues originate from leasing real estate and selling non-cannabis related products. Diego Pellicer does not grow or sell marijuana or marijuana infused products. It leases legally compliant locations for growing, retailing, or the medical dispensing of marijuana.

Diego Pellicer participates in the profit of café operations of non-infused products; participates in the profit of ancillary products, including branded apparel; and in some instances, it signs contracts with its tenants, with the right to acquire at its discretion. The Company has secured many first-rate locations in Colorado, Washington, and Oregon.

Diego Pellicer Worldwide has leased two facilities to grow operators in Denver, Colorado. These grow facilities are licensed for medical and recreational cannabis. The facilities are greater than 30,000 sq. ft.

The Company’s first flagship store tenant, Diego Pellicer-Washington (3,000 sq. ft. space) passed its final inspection for retail marijuana sales and began operations in Q4 2016. This flagship store features high-end cannabis products and accessories.

Diego Pellicer Worldwide has partnered with world-class architect Mr. Michael Rotondi, FAIA, and creative trailblazer Ms. Jill Savini to develop retail prototypes and innovative branding for future store locations. Mr. Rotondi’s Los Angeles, California-based firm, RoTo Architects, is the official architecture agency of record for Diego Pellicer Worldwide.

Ms. Savini, as head of corporate branding for Diego Pellicer Worldwide, is responsible for ensuring a consistent look and branding across retail locations.

Earlier this month, Diego Pellicer-Colorado announced the release of a limited edition glass bubble cap filled with premium live sugar from Harmony Extracts. The bubble cap (created by Wildfire Glass) is placed on top of a heated quartz banger. Within seconds, the live sugar will drip and the concentrate can be smoked. The Harmony Extracts filled bubble cap is now available exclusively at Diego Pellicer in Denver.

Last week, Diego Pellicer-Washington introduced "El Dorado:" This is the world's only $10,000, 24-Karat Gold Cannabis Cigar. It is 28 grams of Tangie flower, wrapped in solvent-free hash rosin, then covered in a layer of premium cannabis fan leaves, and wrapped in a layer of 24-karat, edible gold leaf. The "El Dorado" Gold Cannagar features a 14-karat gold band and a 24-karat gold cutter and torch all packaged in its own humidor.

Diego Pellicer Worldwide, Inc. (DPWW), closed Tuesday's trading session at $0.0134, down 2.90%, on 4,170,821 volume with 78 trades. The average volume for the last 60 days is 1,761,480 and the stock's 52-week low/high is $0.0115/$0.215.

chart

Relmada Therapeutics, Inc. (RLMD)

Dividend Opportunities, StreetAuthority Financial, SmallCap Network, Trade of the Week, Investopedia, ProfitableTrading, Wallstreetbuzz, Investors Alley, The Observer, PCG Advisory, Streetwise Reports, Penny Stock Bets, and WallstreetsHotteststocks reported on Relmada Therapeutics, Inc. (RLMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Relmada Therapeutics, Inc. is a clinical-stage, specialty pharmaceutical company. It centers on developing novel versions of proven drug products in combination with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The Company has a diverse portfolio of lead products at different stages of development. It is developing novel therapies for the treatment of central nervous system (CNS) diseases. Relmada Therapeutics is headquartered in New York, New York.

The Company’s lead products are d-Methadone (REL-1017), its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine -MepiGel (REL-1021), its orphan drug designated topical formulation of the local anaesthetic mepivacaine; oral buprenorphine - BuTab (REL-1028), its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol.

BuTab (REL-1028) is its investigational, oral formulation of buprenorphine - an opioid that is extensively used to treat addiction and chronic pain. The design of BuTab is to be delivered orally and reach safe and effective blood levels of buprenorphine through the gastrointestinal route of administration due to its modified release profile.

Relmada Therapeutics announced in April 2017 that the Food and Drug Administration (FDA) granted Fast Track designation for d-Methadone (REL-1017 dextromethadone), Relmada’s novel N-methyl-D-aspartate (NMDA) receptor antagonist in development for the adjunctive treatment of major depressive disorder.

Relmada Therapeutics announced earlier that the European Patent Office issued a notice of allowance for patent application number 13773543.7 for "D-methadone for the treatment of psychiatric symptoms." This patent provides wide-ranging coverage in Europe for d-Methadone (dextromethadone, REL-1017). Moreover, the Company earlier announced that it acquired the international rights to develop and market dextromethadone (REL-1017).

Recently, Relmada Therapeutics announced that Dr. Ottavio Vitolo joined the Company as Senior Vice President, Head of Research and Development and Chief Medical Officer. Dr. Vitolo earlier served as Executive Clinical Advisor of Relmada since June 2017.

In this new role, Dr. Vitolo will manage the clinical development program for Relmada Therapeutics’ lead product candidate, dextromethadone (REL-1017), and will lead the expansion of the portfolio to other CNS indications.

Relmada Therapeutics, Inc. (RLMD), closed Tuesday's trading session at $1.20, up 15.38%, on 9,276 volume with 15 trades. The average volume for the last 60 days is 21,340 and the stock's 52-week low/high is $0.61/$1.94.

chart

American Cannabis Company, Inc. (AMMJ)

Wall Street Daily, Promotion Stock Secrets, CFN Media Group, The Street, Marketbeat, Cannabis Financial Network News, Stock News Now, Wealth Insider Alert, Market Intelligence Central, and TheOTCInvestor reported on American Cannabis Company, Inc. (AMMJ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Cannabis Company, Inc. is a full-service Business-to-Business (B2B) consulting solutions provider. It is also a seller of ancillary products to the cannabis industry. The Company provides end-to-end solutions to existing and ambitious participants in the cannabis industry. American Cannabis supports its clients from concept to creation, commercialization and continuing operations. American Cannabis Company has its head office in Denver, Colorado.

The Company provides complete consulting management and products solutions to the regulated cannabis markets. It uses its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure, and establish operational best practices.

American Cannabis has its proprietary product called SoHum Living Soils™. SoHum Living Soils™ is a proprietary "just add water" growing medium. It contains 100 percent natural ingredients. SoHum Living Soils™ provides the plant a complete buffet of macro/micro nutrients to realize genetic optimization of the cannabis plant.

The Company also owns The Cultivation Cube™, and The High Density Cultivation System™. These are proprietary cultivation products.

Regarding Consulting, American Cannabis provides application support, business planning, site selection, and regulatory compliance, among other services. Pertaining to Management, the Company provides yield analysis, staffing, business coaching, and staff training and education, and more.

Concerning Products, American Cannabis provides a comprehensive organic grow system, retail solutions (the Satchel™), and grow components. In addition, it provides group purchasing discounts for supplies. The Satchel is a child-proof, tamper-proof vessel for dispensaries. The Satchel™ may be used by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each State's legislation.

American Cannabis has secured a consulting contract with Cloud 9 Apothecary in California. In association with the consulting agreement, it will acquire an equity stake in Cloud 9’s project that is now non-operational and in the development stage.

The project will comprise a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars. This project will be built-out and completed in Desert Springs, California.

American Cannabis Company, Inc. (AMMJ), closed Tuesday's trading session at $0.6755, up 3.13%, on 847,783 volume with 4,210 trades. The average volume for the last 60 days is 438,827 and the stock's 52-week low/high is $8.30/$23.70.

chart

ZIVO Bioscience, Inc. (ZIVO)

RedChip, Marketbeat, Street Insider, Business Insider, Wallet Investor, Zacks, Ceocast News, MarketWatch, and Marketwired reported previously on ZIVO Bioscience, Inc. (ZIVO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ZIVO Bioscience, Inc.’s commitment is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. In addition, ZIVO engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation.

ZIVO Bioscience is headquartered in Keego Harbor, Michigan. The Company’s wholly-owned subsidiary is WellMetris, LLC.

ZIVO Bioscience is re-inventing itself as a licensor of internally developed intellectual property (IP) that includes its proprietary algae cultures, in addition to IP secured by way of strategic acquisitions. The Company is a biotech/agtech R&D company involved in the commercialization of nutritional and medicinal products derived from proprietary algal strains.

ZIVO Bioscience works to completely harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form. It has more recently continued to focus almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize the algal biomass.

The Company’s core IP consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, and also the application of that culture or extract in supporting health maintenance and longevity. ZIVO’s plan is to approach the near-term markets first: animal applications, human food ingredients and human dietary supplements.

Earlier this month, ZIVO Bioscience announced that it received positive results from a discovery-stage efficacy pilot experiment designed to test the efficacy of certain lead compounds against well-known bacterial infections that cause bovine mastitis. This latest experiment builds on earlier in vitro research and an in vivo efficacy study that showed that bioactive compounds produced by ZIVO’s proprietary strain of algae showed efficacy in fighting the effects of bovine mastitis caused by mycoplasma bovis (a drug-resistant infective pathogen).

Last week, ZIVO Bioscience announced that Mr. Ronald C. Costephens joined the Company as Vice-President- Global Operations. Mr. Costephens responsibilities include building out a worldwide supply chain and an organization to help transition ZIVO Bioscience from an R&D entity into an operating business, which will engage in the licensing of its IP portfolio, and also in handling the production and distribution of bulk and finished food, beverage and feed products featuring its proprietary algal strains.

ZIVO Bioscience, Inc. (ZIVO), closed Tuesday's trading session at $0.17, up 0.06%, on 310,375 volume with 11 trades. The average volume for the last 60 days is 92,438 and the stock's 52-week low/high is $0.055/$0.19.

chart

Walker Innovation, Inc. (WLKR)

Wall Street Mover, Marketbeat, TradingView and MarketWatch reported on Walker Innovation, Inc. (WLKR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Walker Innovation, Inc. is an innovation services business that helps companies improve their internal product and business development efforts. Additionally, the Company owns a portfolio of its own intellectual property (IP). Walker Innovation looks to commercialize, license, and enforce the inventive portfolio of IP developed by inventor and entrepreneur, Mr. Jay Walker, who serves as Walker Innovation’s Executive Chairman. Mr. Walker is best known as the Founder of Priceline.com.

Walker Innovation is headquartered in Stamford, Connecticut. Incorporated in 2002, the Company lists on the OTC Markets Group’s OTCQB. It previously went by the name Patent Properties, Inc. It changed its name to Walker Innovation, Inc. in July of 2015.

Walker Innovation’s patent portfolio comprises 400 granted patents and approximately 60 pending patent applications. The Licensing and Enforcement division’s patents describe inventions in areas including authentication techniques, Internet search, social networking, advertising, online transactions, and others.

The Licensing and Enforcement division grants IP rights for the use of, or concerning, patented technologies. This division monetizes its IP via the sale of select patent assets.

Walker Innovation’s current plan of operations includes the start of an effort to acquire, by way of merger, share exchange, or other transactions, one or more operating businesses, or control of such operating businesses through contractual arrangements.

Regarding its Q1 2018 results, Walker Innovation reported no Revenue for both Q1 of 2018 and 2017. The Company stated that the timing and results of patent prosecution and the Company’s enforcement proceedings relating to its IP rights fluctuate from period to period and is unpredictable.

As of March 31, 2018, Walker Innovation had greater than $23 million in cash, cash equivalents and short-term investments, as well as no outstanding long-term debt on its consolidated balance sheet. It reported a Net Loss for Q1 of 2018 of $0.6 million, or ($0.03) per common share, versus a Net Loss of $1.2 million, or ($0.06) per common share, in the year-ago period.

Walker Innovation, Inc. (WLKR), closed Tuesday's trading session at $0.462, down 3.75%, on 12,905 volume with 6 trades. The average volume for the last 60 days is 14,962 and the stock's 52-week low/high is $0.33/$0.62.

chart

AudioEye, Inc. (AEYE)

Monster Stocks, PennyStocks24, FreeRealTime, Wall Street Mover, Wall Street Resources, BUYINS.NET, and TheMicrocapNews reported previously on AudioEye, Inc. (AEYE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AudioEye, Inc.’s emphasis is on improving the mobility, usability, and accessibility of all Internet-based content. This is through the development, sale, licensing, and use of its proprietary accessibility technologies. The Company’s aim is transforming how the world experiences digital content through building pioneering technology to make all digital content easier to consume and compliant with accessibility standards. OTCQB-listed, AudioEye has offices in Tucson, Arizona; Atlanta, Georgia; and Washington, D.C.

The Company is the creator of the world’s first and only cloud-based cross-platform/cross-browser screen reader solution for web browsing. AudioEye’s focus is to provide solutions that create better and more complete access to the Internet, print, broadcast, and other media. This is regardless of one’s network connection, device, location, or specific abilities.

AudioEye has developed patented Internet content publication and distribution software. This software permits the conversion of any media into an audio-accessible format. It also allows real-time distribution to end-users on any Internet-connected device.

AudioEye has its Ally™ platform. The Ally+ product enables the Company’s clients to reach more customers, build more brand loyalty, keep more customers and secure more repeat business. AudioEye launched its Ally™ platform. This platform provides a complete, multi-layered solution for organizations looking to comply with Section 508 best practices.

Additionally, the Company’s solutions include comprehensive E-Learning and E-Commerce systems, along with a variety of Internet publishing products and services. AudioEye’s technology uses its patented architecture to deliver a fully accessible audio equivalent of a visual website or mobile website in a compliant format that can be navigated, used, interacted with, and transacted from without the use of a monitor or mouse, by individuals with visual impairments.

The AudioEye Platform is an entirely scalable cloud-based solution. For individuals with hearing impairments, AudioEye’s technology provides captioning for websites. Furthermore, the challenges of reaching those with other impairments are addressed by the technology platform.

In October, AudioEye announced that it, in partnership with Global TechPro, LLC, was selected by a large federal agency to provide web usability tools for their public-facing website. The site experiences average monthly visits between 12.9 and 22 million. In addition, this site is accessed by greater than 65,000 federal employees. Global TechPro is a CMMI Level 3, multi-disciplined, professional Information Technology (IT) services firm.

AudioEye announced this month that Mr. Todd Bankofier, Chief Executive Officer, will present at the 10th Annual LD Micro Main Event Conference on Tuesday, December 5, 2017, at 9:00 am Pacific Time. This event will take place at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Moreover, Mr. Bankofier will be available to meet with investors throughout the day.

For Q3 2017 (ended September 30, 2017), AudioEye increased revenue 163 percent year-over-year, to $744,000, versus $283,000 in Q3 of 2016. The Company grew year-to-date revenue by 214 percent versus the same nine-month period of 2016, to $1.9 million.

AudioEye, Inc. (AEYE), closed Tuesday's trading session at $0.21, up 3.50%, on 290,097 volume with 28 trades. The average volume for the last 60 days is 99,701 and the stock's 52-week low/high is $0.095/$0.30.

chart

Dakota Territory Resource Corp. (DTRC)

Innovative Marketing, OTC Markets Group, and UltimatePennyStock reported previously on Dakota Territory Resource Corp. (DTRC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Dakota Territory Resource Corp.’s concentration is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three mineral properties. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these are in the heart of the Homestake District. Dakota Territory Resource has its corporate headquarters in Reno, Nevada.

The Blind Gold Property is the Company’s flagship property. It is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is roughly four miles northwest and on structural trend with the historic Homestake Gold Mine. The Homestake Gold Mine produced approximately 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.

Dakota Territory Resource’s intention is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. This program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne. Dakota is preparing for drilling in the Homestake Gold District of South Dakota.

The Homestake Paleoplacer Property comprises 13 unpatented lode mining claims. These are situated one-mile north of the Homestake Open Cut. Dakota Territory Resource based the acquisition of its Black Hills property position on greater than 44 years of combined mining and exploration experience in the Homestake District.

The Company’s City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek comprises 21 unpatented lode mining claims. These are positioned one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.

Dakota Territory Resource announced in April 2017 that it entered into agreements with Trucano Novelty, Inc. to acquire a combination of surface and mineral title to 284 acres in the Homestake District of the Northern Black Hills of South Dakota. Dakota presently holds about 3,341 acres in the heart of the district. Moreover, Dakota Territory Resource’s research of historic data identified high grade gold mineralization under the Company’s recently acquired property at Maitland.

Dakota Territory Resource Corp. (DTRC), closed Tuesday's trading session at $0.065, up 23.81%, on 1,000 volume with 1 trade. The average volume for the last 60 days is 10,825 and the stock's 52-week low/high is $0.03/$0.10.

chart

Repro Med Systems, Inc. (REPR)

Zacks, Market Exclusive, Streetwise Reports, Equity Clock, Marketbeat, Business Wire, Simply Wall St, Stockhouse, 4-Traders, Street Insider, and Stock News Times reported on Repro Med Systems, Inc. (REPR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Repro Med Systems, Inc. (d/b/a RMS Medical Products) develops, manufactures and commercializes medical products used for home infusions and suctioning. The Company is a foremost developer and manufacturer of medical devices and supplies. It focuses on designing and manufacturing safe, affordable medical devices to make quality healthcare a reality for all.

The Company’s products, as well as product support, are provided globally by RMS and via an international network of distributors and service providers. Repro Med Systems’ shares trade on the OTCQX. The Company has its corporate headquarters in Chester, New York.

Repro Med Systems’ main products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™, and RES-Q-VAC® Hand Held Medical Suction.

The FREEDOM Syringe Infusion System presently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings and also at home. Repro Med's RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to an array of other healthcare providers.

The Company’s products do not rely on batteries or electric power. Therefore, this makes them dependable in critical situations. Repro Med Systems specializes in developing and manufacturing portable medical devices and supplies for a broad spectrum of markets. This includes hospitals, home healthcare, nursing homes, as well as rescue services.

Recently, Repro Med Systems (d/b/a RMS Medical Products) announced that the United States Court of Appeals for the Federal Circuit shot down EMED's appeal and that nine of the ten claims in EMED's patent were invalid. The Company and EMED have been involved in continuing litigation for some time.

On April 3, 2018 the CAFC issued its decision. The CAFC's Judgement affirmed the Final Written Decision of the PTAB invaliding claims 1-8 and 10 of EMED's '476 patent.

Mr. Andy Sealfon, RMS Chief Executive Officer, said, "The court's decision further validates RMS's leading status as an innovator in home infusion. While we are pleased with the result, we want to assure our partners that despite all of this unwarranted legal interference, RMS remains focused on its mission to improve the quality of life of patients around the world."

Repro Med Systems, Inc. (REPR), closed Tuesday's trading session at $1.26, up 5.88%, on 1,800 volume with 5 trades. The average volume for the last 60 days is 20,886 and the stock's 52-week low/high is $0.34/$1.50.

chart

Mymetics Corp. (MYMX)

TopPennyStockMovers, Market Intel Reports, and The Dean reported previously on Mymetics Corp. (MYMX), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Mymetics Corp. is a biotechnology company listed on the OTC Markets Group’s OTCQB. The Company is developing next-generation preventative vaccines for infectious diseases. Its vision is to become the market leader in the development of new generation mucosal and virosomes based vaccines. Mymetics has its corporate office in Epalinges, Switzerland.

Mymetics has a Research Lab in the Netherlands. The Company’s core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Currently, Mymetics has a group of vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes Simplex Virus, and the RSV vaccine.

The design of the Company’s vaccines is to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which for some pathogens may be critical for the development of an effective prophylactic vaccine. The HIV, malaria, and intra-nasal influenza vaccines have successfully completed Phase 1 clinical trials. The others are in the pre-clinical phase.

Mymetics is concentrating on developing pioneering preventative vaccines utilizing two key scientific approaches. One is Virosomes as an effective adjuvant and a vaccine delivery method. The other is unique antigen design through generating mucosal antibodies.

Through focusing on these two scientific approaches, Mymetics’ strategy is addressing two important needs in developing effective vaccines. One is the ability to build a first line of defense against viruses entering the blood stream through centering on the mucosal layer. The other is the development of a new vaccine delivery platform that doesn’t use live attenuated or killed pathogens, while increasing the immunogenicity and stability of the vaccine.

Mymetics’ subsidiary, Mymetics B.V., has agreed on a research project with Sanofi Pasteur, the vaccine division of Sanofi (SNY). The project will investigate the immunogenicity of influenza vaccines based on Mymetics' proprietary virosome technology platform in pre-clinical settings.

Mymetics has recently presented new preclinical data. The new data demonstrates that nasal powder, oral capsules, and sublingual tablets developed by MACIVIVA partners, containing Mymetics HIV-1 virosome based vaccine candidate, could induce specific antibody immune response in rodent and mini-pig animal models.

The results are generated under the MACIVIVA project (an EU Horizon 2020 project) that stands for "Manufacturing process for Cold-chain Independent Virosome-based Vaccines." The project began in May of 2015. It has a duration total of 3.5 years.

This project brings together top contract manufacturers and the relevant expertise for spray drying, freeze drying, and analytical techniques from the pharmaceutical industry. This is to develop a scalable manufacturing process to attain thermostable and cold-chain independent virosome based vaccines.

Mymetics Corp. (MYMX), closed Tuesday's trading session at $0.04326, up 0.14%, on 12,000 volume with 3 trades. The average volume for the last 60 days is 264,791 and the stock's 52-week low/high is $0.0155/$0.095.

chart

Glance Technologies, Inc. (GLNNF)

InvestorsHub, MarketWatch, Evergreen Caller, and Emerging Growth reported on Glance Technologies, Inc. (GLNNF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Glance Technologies, Inc. owns and operates Glance Pay. This is a streamlined payment system. It transforms how smartphone users choose where to dine, order food and drink, settle bills, access digital receipts, earn premier rewards, and interact with merchants. Concerning the Glance Pay mobile payment app, there is no set up or cancellation fees and no system integration or connections required. OTCQB-listed, Glance Technologies is based in Vancouver, British Columbia.

The Glance Pay mobile payment app works for full service restaurants, quick serve, retail, and more. Moreover, it features easy activation and training and easy automatic accounting and reconciliation, and fast payment deposits. Servers and managers can review transaction details.

Glance Technologies is building a valuable network of merchants and consumers. The Company offers targeted in-app marketing, social media marketing, customer feedback, in-merchant messaging, and custom rewards programs.

The Glance Pay mobile payment system consists of proprietary technology. This technology includes user apps available for free downloads in IOS (Apple) and Android formats, a merchant manager apps, a large-scale technology hosting environment with sophisticated anti-fraud technology, and very fast payment processing.

Glance Technologies earlier agreed to license its mobile payment technology to Active Pay Distribution, Inc. for $1,000,000. This marks Glance Technologies’ entry into the fitness and wellness market.

With the deal, Glance Pay will create and provide the technology backbone for the Active Pay app, which will serve the growing fitness and wellness community. The app will be called Active Pay. It will be uniquely branded as Active Pay. Nonetheless, it will be labeled as "powered by Glance Pay".

Glance Technologies plans to launch a "Glance" token that will be granted as a reward to users of the Glance Pay mobile payment app every time they make a payment on the Glance Pay mobile network. The reward will apply to all payments, whether the payment is made with the new cryptocurrency or by other payment methods. In addition, the Company intends to apply elements of its anti-fraud technology to cryptocurrencies to lessen the risk associated with converting traditional currencies to and from cryptocurrencies.

Glance Technologies has entered into a non-binding Letter of Intent (LOI) to acquire Blockimpact from Ztudium Limited. Blockimpact is a blockchain and cryptocurrency with a rewards tokenization platform. With this LOI, Glance will acquire all of the intellectual property (IP) consisting of the Blockimpact platform for a cost of US$1.1 million. Blockimpact is a full end-to-end cryptocurrency blockchain solution.

Glance Technologies, Inc. (GLNNF), closed Tuesday's trading session at $0.37297, up 2.18%, on 265,141 volume with 92 trades. The average volume for the last 60 days is 617,532 and the stock's 52-week low/high is $0.11/$3.20.

chart

The QualityStocks Company Corner

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today the signing of a non-binding memorandum of understanding with a direct importer of several leading vehicle manufacturers to Israel.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $3.87, up 12.83%, on 465,867 volume with 1,547 trades. The average volume for the last 60 days is 43,957 and the stock's 52-week low/high is $2.44/$10.45.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) is set to present at NIBA, National Investment Banking Association Conference in New York. In the past six months, SinglePoint completed audits, up-listed to the OTCQB, filed a Form 10 to become a fully reporting company. All with the intention of increasing transparency and allowing for shareholders to have additional flexibility and liquidity.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.048, up 17.30%, on 8,930,832 volume with 450 trades. The average volume for the last 60 days is 10,388,956 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

While the disputes between central bankers and alt-currency traders are an ongoing feature of the fintech market, Virtual Crypto Technologies Inc. (OTCQB: VRCP), a believer in the transformative potential of cryptocurrencies, is helping the industry through its growing pains with transformative technology of its own — crypto-accessible ATM systems that are capable of both fiat-to-crypto and crypto-to-fiat transactions on a real-time basis. Also today, NetworkNewsWire released a report on the company detailing VRCP’s announcement today of the upgraded version of its crypto point-of-sale (POS) terminals and updated NetoBit application named NetoBit Pay.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.1575, up 7.16%, on 18,382 volume with 11 trades. The average volume for the last 60 days is 36,394 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

Medical Cannabis Payment Solutions (OTC: REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC:REFG), a leader in technological solutions for the medical cannabis industry, announced today the company is working on growing industrial hemp as part of Vermont’s industrial hemp program. The company is looking at multiple properties to begin growing and anticipates its first harvest will be in 2019.

Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0429, up 0.66%, on 245,512 volume with 58 trades. The average volume for the last 60 days is 603,464 and the stock's 52-week low/high is $0.0161/$0.092.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

NetworkNewsAudio, via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), a client of NNW positioned in rapidly-growing markets with innovative preventative therapies and a groundbreaking cannabidiol (“CBD”) drug delivery platform. The interview can be heard at http://nnw.fm/gXMx8.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.0616, even for the day. The average volume for the last 60 days is 21,275 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

DeepMarkit Inc. (TSX-V: MKT) (OTCQB: MKTDF)

The QualityStocks Daily Newsletter would like to spotlight DeepMarkit Inc. (MKTDF).

DeepMarkit Corp. (TSX-V: MKT) (OTCQB: MKTDF) this morning issued an update regarding the company’s business development. Per the update, the company has achieved an average of 61% month-over-month growth in its merchant base since the March launch of its slide-out app Gamify for e-commerce websites. To view the full press release, visit: http://nnw.fm/tO5DB. Also today, NetworkNewsWire released a report on the company detailing how MKTDF is “One to Watch.”

DeepMarkit Inc. (TSX-V: MKT) (OTCQB: MKTDF), based in Calgary, Alberta, Canada, is a patent pending gamification technology company inventing new ways to engage consumers and other audiences. The Company’s proprietary promotions platform – “Gamify” – enables businesses and agencies to create branded games that incentivize consumers, thus driving sales, capturing data and generating leads. The DeepMarkit platform integrates next-gen gamification engagement mechanics with interactive advertising industry standards and powerful visuals, including 3-D images. Customers may choose from both free and paid solutions suitable for campaigns of all sizes, targeting multiple channels on the web, mobile and social media.

A team of seasoned, passionate gaming executives, led by president and CEO Darold Parken, has worked together for more than 15 years developing games and gaming systems that are still used today by some of the largest gaming companies in the world. This accomplished executive team founded Chartwell Technologies, acquired in 2011 by Amaya Gaming, which now is known as The Stars Group (Nasdaq: TSG) with a market cap of over $5 billion.

Gamify offers a selection of easily customizable gaming apps featuring a customer’s branded e-store in addition to tailored landing pages, technical support, real-time analytics, data collection and an engaging marketing campaign. Gamify’s patent-pending app comes complete with unique user incentives that draw consumers in with games and prizes, which in turn engages shoppers, turning them into buyers and building brand loyalty.

The gamification market is rapidly expanding and projected to be worth $22 billion by 2022, with a CAGR of 41 percent. DeepMarkit is the only publicly listed company focused solely on this exploding market that embraces any size of business, from the mom-and-pop shops to the blue-chip giants. DeepMarkit’s management team knows that increasing a customer’s conversion rate by a mere 1 percent has the potential to double revenue, which is why Gamify’s app and its ability to transform simple shoppers into engaged buyers is so compelling.

“Our marketing platform enables customers to build branded games that incentivize audiences, generate leads, and drive sales. Businesses need a way to stand out from the crowd,” Parken states in an investor’s video (https://www.youtube.com/watch?v=97hJoRKR92k). “DeepMarkit’s gamification platform gives customers that way to stand out and it’s a way that they can afford. That’s the strength of our platform. For a relatively small amount of money, any business can create a very powerful, high quality customer engagement using gamification.”

DeepMarkit recently entered into a joint marketing agreement with ITN International (“ITN”), a global leader in trade show data capture and analytics. The agreement will enable the 1.5 million exhibitors at the 125-plus yearly events serviced by ITN to purchase a customizable campaign with prize delivery and branded games that can be used in collaboration with ITN’s lead retrieval solutions. DeepMarkit and ITN are currently integrating DeepMarkit’s patent-pending gamification platform directly into ITN’s exhibitor portal.

“We started DeepMarkit because we have a passion for games and we believe in the power of games, not just for entertainment but more importantly as a tool for business,” Parken said. “DeepMarkit is a gamification company. What we mean by that is that we create innovative ways to use games for business purposes. Games to generate customer leads, games to promote products, deliver rewards, build brand awareness and customer loyalty.”

Selected as the winner of the New Company/Product pitch competition at the Retail Global 2017 Conference held in Las Vegas, Gamify’s platform has also attracted a $1.5 million investment from Allstate International LLC in Hong Kong. The investment gives Allstate a 10 percent stake in DeepMarkit and a great opportunity to bring the Gamify platform into the burgeoning Asian gaming market.

DeepMarkit Inc. (MKTDF), closed the day's trading session at $0.0364, even for the day. The average volume for the last 60 days is 38,188 and the stock's 52-week low/high is $0.0293/$0.12.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a report on partner Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P); (WKN: A1C4WM), which announced today that it has agreed to a new $200 million debt facility, with a potential upsize to $250 million, with the Bank of Montreal ("BMO").

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $6.53, off by 4.38%, on 228,771 volume. The stock's 52-week low/high is $3.50/$8.28.

Recent News

chart

EVIO, Inc. (OTCQB: EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that its laboratory located in Berkeley, California, C3 Labs, LLC DBA EVIO Labs, has attained ISO 17025 accreditation from Perry Johnson Laboratory Accreditation, Inc. (“PJLA”). To view the full press release, visit: http://cnw.fm/hDS3l.

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.15, off by 1.71%, on 116,548 volume with 101 trades. The average volume for the last 60 days is 94,905 and the stock's 52-week low/high is $0.47/$2.70.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company" or "Choom"), a fully-integrated cannabis company, is pleased to announce the appointment of Kyp Rowe to the Management team in the role of Director of Operations. Mr. Rowe will be a key member of the Choom team, leading our premium craft cannabis cultivation strategy to support our retail roll-out for the recreational market in Canada. Also today, CHOOF was highlighted in a report on how leading cannabis players are making big moves through real estate investment.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.90, off by 4.46%, on 452,102 volume with 384 trades. The average volume for the last 60 days is 538,627 and the stock's 52-week low/high is $0.18/$1.10.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Lexaria Bioscience Inc. (CSE:LXX) (LXX.CN) (CNSX:LXX) (OTCQX:LXRP). Also today, NetworkNewsWire released a report on the company detailing how LXRP has a wide variety of licensing applications for its patented DehydraTECH™ delivery technology.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $2.01, off by 3.83%, on 228,299 volume with 325 trades. The average volume for the last 60 days is 274,474 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

chart

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR)

The QualityStocks Daily Newsletter would like to spotlight Hammer Fiber Optic Holdings Corp. (HMMR).

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR) technology accomplishes the last mile with a smart hybrid of fiber optic and wireless, making the last mile achievable. The New Jersey based company gets the data in the door using the latest in wireless broadband technology which has been designed to extend powerful fiber technology. Also today, NetworkNewsWire released a report on the company detailing how, as the world prepares for next-generation 5G wireless cell service (http://nnw.fm/6IhoT), HMMR is building its efforts to grow its New Jersey, New York and Pennsylvania base of operations into a national program that will provide service on a neighborhood-access basis.  

Hammer Fiber Optic Holdings Corp. (HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology.

Hammer Fiber recently completed the initial development phase of its advanced LTE fixed wireless system, which was designed and built upon its successfully deployed wireless technology suite. The expansion allows Hammer Fiber to add ultra-high capacity cellular broadband applications to its product portfolio including wholesale services such as backhaul support for cellular network operators. Designed to complement Hammer Fiber’s core business of home residential service, the company expects this latest innovation to help position Hammer Fiber as a leader in future 5G technology. The company intends to leverage the Fixed LTE system in conjunction with its already deployed Fixed Wireless DOCSIS 3.1 system to deliver on one of its core promises, to deliver high capacity broadband to markets across the country at dramatically lower cost than traditional wireline methods, including fiber. Live field testing of the new system begins in early 2018 in the U.S. with service availability to follow later in the year.

Hammer Fiber has also expanded its IaaS (Infrastructure-as-a-Service) cloud services to include support for the cryptocurrency and blockchain industry. Interested companies will be able to host their products over Hammer Fiber’s robust and modern server infrastructure, fiber network architecture and data center presence in some of the most secure locations in the New York, New Jersey and Philadelphia regions. Hammer Fiber’s servers feature best-in-class computing power, designed to allow enterprise businesses to reap the benefits of utilizing a cloud-based system without the massive cost of establishing or maintaining a corporate data center.

“Distributed architecture infrastructure, such as those utilized by blockchain entities mining cryptocurrencies or other new vertical markets utilizing blockchain technology, are growing exponentially and we are poised to fulfill a critical but fundamental need of this explosive new industry,” said Mark Stogdill, CEO of Hammer Fiber. “The distributed ledger architectures that blockchains are built on require secure and robust data processing networks, highly scalable power generation and a reliable fiber optic backbone infrastructure linking up data centers worldwide for them to exist, and that is what we at Hammer Fiber do really well.”

Hammer Fiber seeks to achieve its vision by employing an extremely qualified group of business professionals with diverse backgrounds and successful track records from a variety of related industries. HMMR’s seasoned leadership team combines startup expertise with a consummate understanding of the regional competitive telecommunications landscape in sales, marketing, engineering, construction and business development.

Hammer Fiber Optic Holdings Corp. (HMMR), closed the day's trading session at $1.12, off by 1.75%, on 126,049 volume with 207 trades. The average volume for the last 60 days is 82,560 and the stock's 52-week low/high is $0.882/$48.00.

Recent News

chart

Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services (OTC Markets:SHRV) today announces that its wholly owned subsidiary, Elevacity Global, LLC, plans to launch its product line in Australia and New Zealand in 2018. The company has initiated the first steps necessary from a legal and compliance standpoint and will expediate the process to quickly fulfill consumer demand in those countries.

Sharing Services, Inc. (OTC: SHRV) headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth, and sending as many successful company “families” as possible on vacation.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.325, off by 4.41%, on 20,330 volume with 13 trades. The average volume for the last 60 days is 35,498 and the stock's 52-week low/high is $0.125/$1.07.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.